Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-15 Baynes Roy D. Director Grant or award +6,500 37,500
2025-05-15 Baynes Roy D. Director Grant or award · Stock option (right to buy) +19,500 19,500
2025-05-05 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −1,784 $21.05 $38K 93,126
2025-05-05 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −18,924 $21.05 $398K 419,173
2025-05-05 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −1,771 $21.05 $37K 128,215
2025-05-05 ROTE WILLIAM E. Chief Research Officer Sale 10b5-1 −3,198 $21.05 $67K 100,241
2025-05-05 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −4,920 $21.05 $104K 89,482
2025-05-02 Cline Christopher R. CHIEF FINANCIAL OFFICER Option exercise +4,920 94,910
2025-05-02 Cline Christopher R. CHIEF FINANCIAL OFFICER Option exercise · Performance-based restricted stock units −4,920 4,920
2025-05-02 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +18,924 438,097
2025-05-02 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise · Performance-based restricted stock units 10b5-1 −18,924 18,924
2025-05-02 Heerma Peter CHIEF COMMERCIAL OFFICER Option exercise +4,920 129,986
2025-05-02 Heerma Peter CHIEF COMMERCIAL OFFICER Option exercise · Performance-based restricted stock units −4,920 4,920
2025-05-02 ROTE WILLIAM E. Chief Research Officer Option exercise 10b5-1 +4,920 103,439
2025-05-02 ROTE WILLIAM E. Chief Research Officer Option exercise · Performance-based restricted stock units 10b5-1 −4,920 4,920
2025-05-02 REED ELIZABETH E Chief Legal Officer and GC Option exercise 10b5-1 +4,920 94,402
2025-05-02 REED ELIZABETH E Chief Legal Officer and GC Option exercise · Performance-based restricted stock units 10b5-1 −4,920 4,920
2025-04-11 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −48 $13.14 $631 89,990
2025-02-12 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale 10b5-1 −5,200 $23.53 $122K 98,519
2025-02-12 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale 10b5-1 −8,000 $23.53 $188K 89,482

Page 18 of 51 · 1,020 trades